Indefinite Delivery Contract SPE2DR25D9766

The provided information describes a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The IDC, valued at $499,999,999 and valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain and provides direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The IDC was not set aside for any specific business size or socioeconomic status, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this direct federal award.